Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1993;20(3):188–197.

Depression and its treatment in cardiac patients.

F Fernandez 1
PMCID: PMC325091  PMID: 8219822

Abstract

In general medical-surgical hospital services, depression is the most common reason for seeking psychiatric consultation in behalf of patients with cardiovascular disease. The nontreatment of depression or the use of a psychotropic agent mismatched to a patient's particular cardiac condition or individual sensitivities has considerable negative impact. Therefore, a systematic approach should be used in the differential diagnosis of depression in cardiac patients, to eliminate other psychiatric disorders and to assure the correct treatment strategy. Physicians can develop an appropriate rationale for the use of a psychopharmacologic regimen in cardiovascular settings through recognition of the diagnostic criteria for depression and through comprehensive knowledge of the pharmacologic properties and possible cardiovascular effects of these vital treatments. Standard and alternative pharmacotherapies for depression in cardiac patients are reviewed.

Full text

PDF
188

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arana G. W., Baldessarini R. J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry. 1985 Dec;42(12):1193–1204. doi: 10.1001/archpsyc.1985.01790350067012. [DOI] [PubMed] [Google Scholar]
  2. Avery D., Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry. 1976 Sep;33(9):1029–1037. doi: 10.1001/archpsyc.1976.01770090019001. [DOI] [PubMed] [Google Scholar]
  3. Barletta M. A., Eisen H. Isosorbide dinitrate-disopyramide phosphate interaction. Drug Intell Clin Pharm. 1985 Oct;19(10):764–764. doi: 10.1177/106002808501901020. [DOI] [PubMed] [Google Scholar]
  4. Black D. W., Winokur G., Nasrallah A. Mortality in patients with primary unipolar depression, secondary unipolar depression, and bipolar affective disorder: a comparison with general population mortality. Int J Psychiatry Med. 1987;17(4):351–360. doi: 10.2190/vl1b-7yee-91j5-mwra. [DOI] [PubMed] [Google Scholar]
  5. Blumenthal J. A., Williams R. S., Wallace A. G., Williams R. B., Jr, Needles T. L. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med. 1982 Dec;44(6):519–527. doi: 10.1097/00006842-198212000-00003. [DOI] [PubMed] [Google Scholar]
  6. Buff D. D., Brenner R., Kirtane S. S., Gilboa R. Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry. 1991 Apr;52(4):174–176. [PubMed] [Google Scholar]
  7. Carney R. M., Rich M. W., Freedland K. E., Saini J., teVelde A., Simeone C., Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988 Nov-Dec;50(6):627–633. doi: 10.1097/00006842-198811000-00009. [DOI] [PubMed] [Google Scholar]
  8. Cassem E. H. Depression and anxiety secondary to medical illness. Psychiatr Clin North Am. 1990 Dec;13(4):597–612. [PubMed] [Google Scholar]
  9. Cavanaugh S., Clark D. C., Gibbons R. D. Diagnosing depression in the hospitalized medically ill. Psychosomatics. 1983 Sep;24(9):809–815. doi: 10.1016/S0033-3182(83)73151-8. [DOI] [PubMed] [Google Scholar]
  10. Cohen-Cole S. A., Stoudemire A. Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am. 1987 Mar;10(1):1–17. [PubMed] [Google Scholar]
  11. Dessain E. C., Schatzberg A. F., Woods B. T., Cole J. O. Maprotiline treatment in depression. A perspective on seizures. Arch Gen Psychiatry. 1986 Jan;43(1):86–90. doi: 10.1001/archpsyc.1986.01800010088011. [DOI] [PubMed] [Google Scholar]
  12. Ellison J. M., Milofsky J. E., Ely E. Fluoxetine-induced bradycardia and syncope in two patients. J Clin Psychiatry. 1990 Sep;51(9):385–386. [PubMed] [Google Scholar]
  13. Finnegan D. L., Suler J. R. Psychological factors associated with maintenance of improved health behaviors in postcoronary patients. J Psychol. 1985 Jan;119(1):87–94. doi: 10.1080/00223980.1985.9712610. [DOI] [PubMed] [Google Scholar]
  14. Fisch C. Effect of fluoxetine on the electrocardiogram. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):42–44. [PubMed] [Google Scholar]
  15. Giardina E. G., Johnson L. L., Vita J., Bigger J. T., Jr, Brem R. F. Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias. Am Heart J. 1985 May;109(5 Pt 1):992–998. doi: 10.1016/0002-8703(85)90240-6. [DOI] [PubMed] [Google Scholar]
  16. Glassman A. H., Bigger J. T., Jr Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry. 1981 Jul;38(7):815–820. doi: 10.1001/archpsyc.1981.01780320095011. [DOI] [PubMed] [Google Scholar]
  17. Glassman A. H., Bigger J. T., Jr, Giardina E. V., Kantor S. J., Perel J. M., Davies M. Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet. 1979 Mar 3;1(8114):468–472. doi: 10.1016/s0140-6736(79)90824-9. [DOI] [PubMed] [Google Scholar]
  18. Glassman A. H., Johnson L. L., Giardina E. G., Walsh B. T., Roose S. P., Cooper T. B., Bigger J. T., Jr The use of imipramine in depressed patients with congestive heart failure. JAMA. 1983 Oct 21;250(15):1997–2001. [PubMed] [Google Scholar]
  19. Goldstein M. G., Guttmacher L. B. Treatment of the cardiac-impaired depressed patient. Part I: General considerations, heterocyclic antidepressants, and monoamine oxidase inhibitors. Psychiatr Med. 1988;6(3):1–33. [PubMed] [Google Scholar]
  20. Guttmacher L. B., Goldstein M. G. Treatment of the cardiac-impaired depressed patient. Part II: Lithium, carbamazepine, and electroconvulsive therapy. Psychiatr Med. 1988;6(3):34–51. [PubMed] [Google Scholar]
  21. Hayes J. R., Born G. F., Rosenbaum A. H. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clin Proc. 1977 Aug;52(8):509–512. [PubMed] [Google Scholar]
  22. Kornecki E., Ehrlich Y. H., Lenox R. H. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science. 1984 Dec 21;226(4681):1454–1456. doi: 10.1126/science.6150550. [DOI] [PubMed] [Google Scholar]
  23. Nelson J. C., Jatlow P. I., Bock J., Quinlan D. M., Bowers M. B., Jr Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics. Arch Gen Psychiatry. 1982 Sep;39(9):1055–1061. doi: 10.1001/archpsyc.1982.04290090045010. [DOI] [PubMed] [Google Scholar]
  24. Pohl R., Bridges M., Rainey J. M., Jr, Boudoulas H., Yeragani V. K. Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease. J Clin Psychopharmacol. 1986 Dec;6(6):380–381. [PubMed] [Google Scholar]
  25. Raskind M., Veith R., Barnes R., Gumbrecht G. Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease. Am J Psychiatry. 1982 Sep;139(9):1114–1117. doi: 10.1176/ajp.139.9.1114. [DOI] [PubMed] [Google Scholar]
  26. Ray W. A., Griffin M. R., Schaffner W., Baugh D. K., Melton L. J., 3rd Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987 Feb 12;316(7):363–369. doi: 10.1056/NEJM198702123160702. [DOI] [PubMed] [Google Scholar]
  27. Robbins L. J. Dry mouth and delayed dissolution of sublingual nitroglycerin. N Engl J Med. 1983 Oct 20;309(16):985–985. doi: 10.1056/NEJM198310203091615. [DOI] [PubMed] [Google Scholar]
  28. Roose S. P., Dalack G. W., Glassman A. H., Woodring S., Walsh B. T., Giardina E. G. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry. 1991 Apr;148(4):512–516. doi: 10.1176/ajp.148.4.512. [DOI] [PubMed] [Google Scholar]
  29. Roose S. P., Dalack G. W., Glassman A. H., Woodring S., Walsh B. T., Giardina E. G. Is doxepin a safer tricyclic for the heart? J Clin Psychiatry. 1991 Aug;52(8):338–341. [PubMed] [Google Scholar]
  30. Roose S. P., Dalack G. W. Treating the depressed patient with cardiovascular problems. J Clin Psychiatry. 1992 Sep;53 (Suppl):25–31. [PubMed] [Google Scholar]
  31. Roose S. P., Glassman A. H., Giardina E. G., Johnson L. L., Walsh B. T., Bigger J. T., Jr Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol. 1987 Aug;7(4):247–251. [PubMed] [Google Scholar]
  32. Roose S. P., Glassman A. H., Giardina E. G., Walsh B. T., Woodring S., Bigger J. T. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry. 1987 Mar;44(3):273–275. doi: 10.1001/archpsyc.1987.01800150093011. [DOI] [PubMed] [Google Scholar]
  33. Roose S. P., Glassman A. H., Siris S. G., Walsh B. T., Bruno R. L., Wright L. B. Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol. 1981 Sep;1(5):316–319. doi: 10.1097/00004714-198109000-00008. [DOI] [PubMed] [Google Scholar]
  34. Schleifer S. J., Macari-Hinson M. M., Coyle D. A., Slater W. R., Kahn M., Gorlin R., Zucker H. D. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989 Aug;149(8):1785–1789. [PubMed] [Google Scholar]
  35. Spier S. A., Frontera M. A. Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry. 1991 Sep;52(9):377–382. [PubMed] [Google Scholar]
  36. Stoudemire A., Atkinson P. Use of cyclic antidepressants in patients with cardiac conduction disturbances. Gen Hosp Psychiatry. 1988 Nov;10(6):389–397. doi: 10.1016/0163-8343(88)90061-8. [DOI] [PubMed] [Google Scholar]
  37. Tufo H. M., Ostfeld A. M., Shekelle R. Central nervous system dysfunction following open-heart surgery. JAMA. 1970 May 25;212(8):1333–1340. [PubMed] [Google Scholar]
  38. Veith R. C., Raskind M. A., Caldwell J. H., Barnes R. F., Gumbrecht G., Ritchie J. L. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med. 1982 Apr 22;306(16):954–959. doi: 10.1056/NEJM198204223061603. [DOI] [PubMed] [Google Scholar]
  39. Vázquez-Barquero J. L., Padierna Acero J. A., Ochoteco A., Díez Manrique J. F. Mental illness and ischemic heart disease: analysis of psychiatric morbidity. Gen Hosp Psychiatry. 1985 Jan;7(1):15–20. doi: 10.1016/0163-8343(85)90005-2. [DOI] [PubMed] [Google Scholar]
  40. Warner M. D., Peabody C. A., Whiteford H. A., Hollister L. E. Alprazolam as an antidepressant. J Clin Psychiatry. 1988 Apr;49(4):148–150. [PubMed] [Google Scholar]
  41. Wishnie H. A., Hackett T. P., Cssem N. H. Psychological hazards of convalescence following myocardial inarction. JAMA. 1971 Feb 22;215(8):1292–1296. [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES